Advanced
search

To read this content please select one of the options below:

Data is destiny: health care and human genomics

Anne‐Katrin Bock (Institute for Prospective Technological Studies, Edificio Expo‐WTC, Calle Inca Garcilaso, s/n, 41092 Seville, Spain)
Dolores Ibarreta (Institute for Prospective Technological Studies, Edificio Expo‐WTC, Calle Inca Garcilaso, s/n, 41092 Seville, Spain)
Karine Lheureux (Institute for Prospective Technological Studies, Edificio Expo‐WTC, Calle Inca Garcilaso, s/n, 41092 Seville, Spain)
Monique Libeau (Institute for Prospective Technological Studies, Edificio Expo‐WTC, Calle Inca Garcilaso, s/n, 41092 Seville, Spain)
Hans Nilsagård (Institute for Prospective Technological Studies, Edificio Expo‐WTC, Calle Inca Garcilaso, s/n, 41092 Seville, Spain)

Foresight

ISSN: 1463-6689

Article publication date: 1 August 2001

311

Abstract

In February this year the sequence of the human genome was published, opening a new chapter in medicine. Soon genetic testing will be at the heart of diagnosis, epidemiology, drug development and even regenerative medicine. Before we are born there will be new opportunities to remedy genetic defects, and afterwards to make almost lifelong prognoses. The debate will intensify on the use of human embryos in medical research, while the prospect of human cloning will fascinate some scientists and horrify others. Europe needs to be in the vanguard of this new industrial revolution, but a host of ethical concerns must first be addressed – because genomics is as much about privacy as Petri dishes.

Keywords

Citation

Bock, A., Ibarreta, D., Lheureux, K., Libeau, M. and Nilsagård, H. (2001), "Data is destiny: health care and human genomics", Foresight, Vol. 3 No. 4, pp. 377-388. https://doi.org/10.1108/14636680110803256

Publisher

:

MCB UP Ltd

Copyright © 2001, MCB UP Limited

Related articles

Manage cookies

We’re listening — tell us what you think

Join us on our journey